Injectable PLGA with EE and DSRP

Description: A drug-delivery system of Poly(D,L-lactic-co-glycolic acid) (PLGA) microparticles and organogels containing drospirenone (DRSP) microcrystals combined with ethinyl estradiol (EE) PLGA microparticles and EE poly(butylcyanoacrylate) (PBCA) microcapsules.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Injectable

Duration Type: Long-acting

Active Pharmaceutical Ingredient (API):
  • ethinyl estradiol
  • drospirenone

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Bayer HealthCare

Project Phase: Discovery and Early Development

Development Stage: Prototype Development

Active Development: No

Additional Information

References:
  • Nippe S. (2012) Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release. Eur J Pharm Sci. 47(4):790-800.

Vertical Tabs

Print